BIG ROCK PARTNERS SPONSOR, LLC (President and CEO) reported 2 transactions at NRX PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/25/2021ACC: 0001094891-21-000212
DirectorOfficer· President and CEO
Since Nov 2018
-150.69K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
127.25K acquired · 277.94K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−5.43K
Price / share
—
Trade value
—
% of position
1.1%
5/24/2021
497.50K→492.06K
Common Stock
Indirect
Shares
+27.25K
Price / share
—
Trade value
—
% of position
5.5%
5/24/2021
492.06K→519.32K
Total
Net shares
+21.82K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/24/2021 | D · Disposition | −5.43K | — | — | 1.1% | 497.50K | 492.06K |
| Common Stock Indirect | 5/24/2021 | C · Conversion | +27.25K | — | — | 5.5% | 492.06K | 519.32K |
| Total | +21.82K | $0.00 | ||||||
Derivative Transactions2
Rights, exchangeable for Common Stock
Indirect
Converts to
Common Stock
27.25K shares
Shares
−272.50K
Strike price
Held after
0.00
Exercisable
—
5/24/2021
Unit Purchase Option
Indirect
Converts to
Common Stock
160K shares
Shares
+100K
Strike price
10
Held after
100K
Exercisable
—
5/24/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Rights, exchangeable for Common Stock Indirect | Common Stock27.25K shares | 5/24/2021 | C · Conversion | −272.50K | — | 0.00 | |
| Unit Purchase Option Indirect | Common Stock160K shares | 5/24/2021 | P · Purchase | +100K | 10 | — | 100K |